Petros Pharmaceuticals, Inc. (PTPI)
CIK 1815903 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Petros Pharmaceuticals, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Aug 13, 2026 | 10-Q | 0001104659-26-095979 |
| Jun 25, 2026 | 3 | 0001104659-26-077822 |
| Jun 18, 2026 | 8-K | 0001104659-26-075849 |
| Jun 8, 2026 | 4 | 0001104659-26-071436 |
| Jun 5, 2026 | 4 | 0001104659-26-071038 |
| Jun 5, 2026 | 4 | 0001104659-26-071039 |
| Jun 5, 2026 | 8-K | 0001104659-26-071027 |
| Jun 5, 2026 | 4 | 0001104659-26-071048 |
| May 13, 2026 | 10-Q | 0001104659-26-060359 |
| Apr 15, 2026 | 10-K | 0001104659-26-043822 |
| Mar 31, 2026 | NT 10-K | 0001104659-26-037800 |
| Feb 17, 2026 | SCHEDULE 13G/A | 0000930413-26-000426 |
| Jan 6, 2026 | 4 | 0001104659-26-001417 |
| Jan 2, 2026 | 8-K | 0001104659-26-000236 |
| Jan 2, 2026 | 4 | 0001104659-26-000233 |
| Jan 2, 2026 | 4 | 0001104659-26-000237 |
| Jan 2, 2026 | 4 | 0001104659-26-000238 |
| Nov 20, 2025 | 25-NSE | 0001354457-25-001163 |
| Nov 13, 2025 | 10-Q | 0001104659-25-111338 |
| Sep 5, 2025 | 8-K | 0001104659-25-087887 |
| Aug 15, 2025 | SCHEDULE 13G/A | 0000930413-25-002483 |
| Aug 14, 2025 | 10-Q | 0001410578-25-001811 |
| Jun 20, 2025 | 8-K | 0001104659-25-061230 |
| Jun 20, 2025 | 8-K | 0001104659-25-061230 |
| May 21, 2025 | 8-K | 0001104659-25-051336 |